---
figid: PMC2912204__JCI44026.f1
figlink: /pmc/articles/PMC2912204/figure/F1/
number: Figure 1
caption: Receptor tyrosine kinases bind with ligand and initiate the signaling pathway
  via intermediate molecules (IRS). PI3K becomes activated, which results in phosphorylation
  of phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate
  (PIP3), a process that is reversed by PTEN. At the cell membrane, proteins with
  pleckstrin homology domains then become phosphorylated via PIP3 (phosphoinositide-dependent
  protein kinase–1 [PDK1] and AKT). PDK1 can also phosphorylate critical residues
  on AKT. The tumor suppressor complex of TSC1/TSC2 normally inhibits mTOR activation
  via Ras homolog enriched in brain (Rheb). Activated AKT prevents this inhibition,
  leading to activation of the mTOR/Raptor complex known as mTOR complex 1 (mTORC1).
  This complex can be inhibited by rapamycin and its analogs, including everolimus.
  Ultimately, mTORC1 leads to the activation of downstream proteins involved in the
  initiation of protein synthesis, resulting in cellular growth. Receptor tyrosine
  kinase activation also initiates MAPK pathway signaling, which leads to cell cycle
  progression and proliferation. MAPK pathway activation can also augment PI3K signaling.
  MEK, MAPK/ERK kinase.
pmcid: PMC2912204
papertitle: 'PIK3CA and KRAS mutations predict for response to everolimus therapy:
  now that’s RAD001             .'
reftext: Morassa Mohseni, et al. J Clin Invest. 2010 Aug 2;120(8):2655-2658.
pmc_ranked_result_index: '649'
pathway_score: 0.9623384
filename: JCI44026.f1.jpg
figtitle: 'PIK3CA and KRAS mutations predict for response to everolimus therapy: now
  that’s RAD001             '
year: '2010'
organisms: Homo sapiens
ndex: 7701e907-ded7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2912204__JCI44026.f1.html
  '@type': Dataset
  description: Receptor tyrosine kinases bind with ligand and initiate the signaling
    pathway via intermediate molecules (IRS). PI3K becomes activated, which results
    in phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol
    3,4,5-trisphosphate (PIP3), a process that is reversed by PTEN. At the cell membrane,
    proteins with pleckstrin homology domains then become phosphorylated via PIP3
    (phosphoinositide-dependent protein kinase–1 [PDK1] and AKT). PDK1 can also phosphorylate
    critical residues on AKT. The tumor suppressor complex of TSC1/TSC2 normally inhibits
    mTOR activation via Ras homolog enriched in brain (Rheb). Activated AKT prevents
    this inhibition, leading to activation of the mTOR/Raptor complex known as mTOR
    complex 1 (mTORC1). This complex can be inhibited by rapamycin and its analogs,
    including everolimus. Ultimately, mTORC1 leads to the activation of downstream
    proteins involved in the initiation of protein synthesis, resulting in cellular
    growth. Receptor tyrosine kinase activation also initiates MAPK pathway signaling,
    which leads to cell cycle progression and proliferation. MAPK pathway activation
    can also augment PI3K signaling. MEK, MAPK/ERK kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRS1
  - PTEN
  - MAPK1
  - PIK3CB
  - PIK3CA
  - PIK3R4
  - PIK3CG
  - PIK3R3
  - ARAF
  - PIK3CD
  - KRAS
  - PIK3R5
  - TSC1
  - TSC2
  - AKT2
  - IRS2
  - MAP2K1
  - MAPK3
  - IRS4
  - RAF1
  - NRAS
  - MAP2K2
  - HRAS
  - RPTOR
  - PIK3R6
  - RHEB
  - AKT1
  - AKT3
  - BRAF
  - PDK1
  - MTOR
  - tyrosine
  - Rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: tyrosine
  source: MESH
  identifier: D014443
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
